Literature DB >> 30890012

Protective effects of resveratrol on hyperoxia-induced lung injury in neonatal rats by alleviating apoptosis and ROS production.

Xiaodan Zhu1, Xiaoping Lei1, Junyi Wang1, Wenbin Dong1.   

Abstract

Background: Bronchopulmonary dysplasia (BPD) is one of the most common long-term lung complications of prematurely born infants caused by prolonged injury and repair during immature lung development. Resveratrol has reported to exert anti-inflammatory, antioxidation, and antiapoptosis effects. This study aimed to investigate the effect of resveratrol in BPD.
Methods: Neonate rats were delivered spontaneously and randomized divided into four groups on postnatal day (PN) 0.5: room air (21% O2)+dimethyl sulfoxide (DMSO), room air + resveratrol, hyperoxia (80%)+DMSO, hyperoxia + resveratrol. Lung tissues were collected on PN1, PN7, and PN14. Protective effects of resveratrol on hyperoxia-induced lung injury were evaluated by hematoxylin and eosin (HE) staining, TUNEL staining, reactive oxygen species (ROS) detection, qRT-PCR, and western blotting.
Results: Hyperoxia-induced alveolar simplification and apoptosis were alleviated by resveratrol; resveratrol reduced ROS production, up-regulated SIRT1, decreased the expressing of p53, and acetyl-p53 in the lung of hyperoxia-exposed neonatal rats.Conclusions: This study showed that resveratrol alleviated hyperoxia-induced apoptosis in neonatal rats lung tissue via reducing ROS and p53. Resveratrol-induced SIRT1 upregulation and acetyl-p53 reduction may also be involved in lung protection.

Entities:  

Keywords:  Bronchopulmonary dysplasia; SIRT1; apoptosis; p53; reactive oxygen species; resveratrol

Mesh:

Substances:

Year:  2019        PMID: 30890012     DOI: 10.1080/14767058.2019.1597846

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  8 in total

1.  Helichrysetin inhibits gastric cancer growth by targeting c-Myc/PDHK1 axis-mediated energy metabolism reprogramming.

Authors:  Ping Wang; Jin-Mei Jin; Xiao-Hui Liang; Ming-Zhu Yu; Chun Yang; Fei Huang; Hui Wu; Bei-Bei Zhang; Xiao-Yan Fei; Zheng-Tao Wang; Ren Xu; Hai-Lian Shi; Xiao-Jun Wu
Journal:  Acta Pharmacol Sin       Date:  2021-08-30       Impact factor: 7.169

Review 2.  Resveratrol Can Attenuate Astrocyte Activation to Treat Spinal Cord Injury by Inhibiting Inflammatory Responses.

Authors:  Ruihua Fan; Yong Zhang; Benson O A Botchway; Xuehong Liu
Journal:  Mol Neurobiol       Date:  2021-08-19       Impact factor: 5.590

3.  Ginkgolide C Alleviates Acute Lung Injury Caused by Paraquat Poisoning via Regulating the Nrf2 and NF-κB Signaling Pathways.

Authors:  Rui Zhang; Cuirong Zhao; Xianwei Gong; Jie Yang; Guifang Zhang; Wen Zhang
Journal:  Oxid Med Cell Longev       Date:  2022-06-06       Impact factor: 7.310

Review 4.  Nanocarrier-mediated antioxidant delivery for liver diseases.

Authors:  Senlin Li; Huiru Li; Xiaoding Xu; Phei Er Saw; Lei Zhang
Journal:  Theranostics       Date:  2020-01-01       Impact factor: 11.556

5.  Pulmonary delivery of resveratrol-β-cyclodextrin inclusion complexes for the prevention of zinc chloride smoke-induced acute lung injury.

Authors:  Wanmei Wang; Yan Liu; Pan Pan; Yueqi Huang; Ting Chen; Tianyu Yuan; Yulong Ma; Guang Han; Jiahuan Li; Yiguang Jin; Fei Xie
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

Review 6.  Oxygen toxicity: cellular mechanisms in normobaric hyperoxia.

Authors:  Ricardo Alva; Maha Mirza; Adam Baiton; Lucas Lazuran; Lyuda Samokysh; Ava Bobinski; Cale Cowan; Alvin Jaimon; Dede Obioru; Tala Al Makhoul; Jeffrey A Stuart
Journal:  Cell Biol Toxicol       Date:  2022-09-16       Impact factor: 6.819

7.  Resveratrol alleviates alveolar epithelial cell injury induced by hyperoxia by reducing apoptosis and mitochondrial dysfunction.

Authors:  Xiaodan Zhu; Fan Wang; Xiaoping Lei; Wenbin Dong
Journal:  Exp Biol Med (Maywood)       Date:  2020-11-20

8.  Prevention of Oxygen-Induced Inflammatory Lung Injury by Caffeine in Neonatal Rats.

Authors:  Stefanie Endesfelder; Evelyn Strauß; Ivo Bendix; Thomas Schmitz; Christoph Bührer
Journal:  Oxid Med Cell Longev       Date:  2020-08-07       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.